
    
      515 patients have been selected among all patients addicted to heroin according ICD-10, in
      maintenance treatment with Eptadone, observed in the involved sites. The investigators have
      used the treatment schemes with Eptadone conform to the registered use.

      The enrollment has been competitive. Patients met incl/excl and that have signed the informed
      consent have been observed for 1 year. Follow up visits have been performed according to
      routine procedures, for patients related to the centres at 3/6/12 months post V1. During the
      visits patients have been assessed by validated and used as clinical practice questionaries.
      Safety and tolerability have been assessed through the collection of adverse reactions and of
      laboratory tests.
    
  